Twilight Litaka Pharma Ltd

Twilight Litaka Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Twilight Litaka Pharma Ltd

₹ 2.88 -4.95%
01 Jan 2015
Company website BSE: 506985 NSE: TWILITAKA
About

Twilight Litaka Pharma Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceuticals business

[ add key points ]
Website BSE NSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 2.88
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -55.8
  • Dividend Yield 0.00 %
  • ROCE -5.36 %
  • ROE %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -38.9% over past five years.
  • Company has high debtors of 2,342 days.
  • Working capital days have increased from 467 days to 1,003 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015
20.29 11.05 10.01 9.26 9.06 3.17 2.30 4.35 2.77
49.12 51.26 23.41 10.32 9.47 2.43 1.85 2.09 4.31
Operating Profit -28.83 -40.21 -13.40 -1.06 -0.41 0.74 0.45 2.26 -1.54
OPM % -142.09% -363.89% -133.87% -11.45% -4.53% 23.34% 19.57% 51.95% -55.60%
0.09 -0.34 0.00 0.00 0.00 -125.45 0.00 -18.75 0.00
Interest -26.86 -6.86 0.16 0.13 0.12 0.00 0.00 0.00 0.00
Depreciation 1.26 1.16 1.10 1.08 1.02 1.24 1.21 0.02 2.45
Profit before tax -3.14 -34.85 -14.66 -2.27 -1.55 -125.95 -0.76 -16.51 -3.99
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-3.14 -34.85 -14.66 -2.27 -1.55 -125.96 -0.76 -16.51 -4.00
EPS in Rs -1.27 -14.06 -5.92 -0.92 -0.63 -50.83 -0.31 -6.66 -1.61
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 15m Jun 2014 TTM
155 197 295 370 492 657 730 338 32 13
139 171 257 322 425 559 662 379 40 11
Operating Profit 16 27 38 49 67 98 69 -41 -9 2
OPM % 10% 13% 13% 13% 14% 15% 9% -12% -28% 15%
2 1 2 3 3 3 -14 -114 -127 -144
Interest 6 7 12 21 26 34 45 1 0 0
Depreciation 2 2 2 3 3 4 5 6 5 5
Profit before tax 10 19 27 28 41 63 4 -162 -141 -147
Tax % 7% 26% 32% 22% 20% 22% 21% 0% 0%
10 14 18 22 33 49 4 -162 -141 -147
EPS in Rs 1.42 -65.52 -56.91 -59.41
Dividend Payout % 0% 8% 12% 10% 10% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: -39%
3 Years: -64%
TTM: -68%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 94%
Stock Price CAGR
10 Years: -2%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
Equity Capital 10 11 11 11 11 11 12 12 12
Reserves 5 24 40 59 95 144 169 6 -133
58 67 120 160 195 258 302 307 307
43 29 48 55 59 66 68 117 129
Total Liabilities 114 131 219 285 360 478 551 442 315
35 30 34 58 67 81 95 88 83
CWIP 0 0 7 5 10 7 7 0 0
Investments 0 0 0 0 0 11 11 11 11
79 101 177 221 283 379 438 344 220
Total Assets 114 131 219 285 360 478 551 442 315

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
-7 -2 -16 5 14 -5 2 -6 2
-1 -1 -25 -25 -30 -25 -19 0 -0
9 3 42 21 17 27 16 4 -1
Net Cash Flow 0 0 0 2 2 -3 -1 -2 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
Debtor Days 119 125 140 141 133 143 163 278 2,342
Inventory Days 57 58 59 68 67 61 50 68 75
Days Payable 50 44 41 35 33 29 22 32 434
Cash Conversion Cycle 127 139 159 174 166 175 191 314 1,983
Working Capital Days 110 131 159 164 165 161 174 224 1,003
ROCE % 30% 28% 25% 25% 27% 14% -12% -5%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports

Credit ratings